Emergent BioSolutions (EBS) Fails to deliver data

Key failure to deliver metrics for Emergent BioSolutions :

• Last SEC data release: 2025-01-31
• Last 15 days FTD volume: C$0.14 M
• Last 3 months FTD volume: C$1.1 M
• Last year FTD volume: C$1.1 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Emergent BioSolutions (EBS) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Emergent BioSolutions (EBS) - since 2013

Emergent BioSolutions (EBS) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Merck MRK	C$69.9 M	C$0.12 B	🇺🇸 USA
SIGA Technologies SIGA	C$0.7 M	C$6.34 M	🇺🇸 USA
GlaxoSmithKline GSK	C$94.71 M	C$0.14 B	🇬🇧 UK
Celldex Therapeutics CLDX	C$1.59 M	C$6.5 M	🇺🇸 USA
Pfizer PFE	C$21.73 M	C$0.33 B	🇺🇸 USA
Teva Pharmaceutical Industries TEVA	C$15.72 M	C$40.98 M	🇮🇱 Israel
Soligenix SNGX	N/A	C$3.57 M	🇺🇸 USA